SCOPUS 정보 검색 플랫폼

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 3, 2001, Pages 118-122

Treating patients with low HDL-cholesterol: Choices, issues and opportunities

(1) Watts, G F a

a UNIVERSITY OF WESTERN AUSTRALIA (Australia)

Author keywords

Fibrates; HDL cholesterol; Statins; Trials; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; DOXAZOSIN; ESTROGEN; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; PRAZOSIN; TRIACYLGLYCEROL;

ADULT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POSTMENOPAUSE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION; UNITED STATES;

EID: 0034954718 PISSN: 14686708 EISSN: None Source Type: Journal
DOI: 10.1186/CVM-2-3-118 Document Type: Review

Times cited : (17)

References (33)

1
- 0025731272
- Prevalence of risk factors in men with premature coronary artery disease
- (1991) Am J Cardiol , vol.67 , pp. 1185-1189
- Genest, J.J.¹ McNamara, J.R.² Salem, D.N.³ Shaefer, E.J.⁴

2
- 0030045883
- High density lipoproteins and coronary heart disease
- (1996) Atherosclerosis , vol.121 , pp. 1-12
- Barter, P.J.¹ Rye, K.-A.²

3
- 0028154543
- Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
- National Cholesterol Education Program.
- (1994) Circulation , vol.89 , pp. 1329-1445

4
- 0032189666
- Prevention of coronary heart disease in clinical practice: Recommendation of the Task Force of the European and other Societies on coronary prevention
- (1999) Eur Heart J , vol.19 , pp. 1434-1503
- Wood, D.¹ De Backer, G.² Faergeman, O.³ Graham, I.⁴ Mancia, G.⁵ Pyörälä, K.⁶

5
- 0032437504
- Joint British recommendations on prevention of coronary heart disease in clinical practice
- British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association
- (1998) Heart , vol.80 , Issue.SUPPL. 2

6
- 0033527030
- Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
- For the Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group
- (1999) N Engl J Med , vol.341 , pp. 410-418
- Rubins, H.B.¹ Robins, S.J.² Collins, D.³ Fye, C.L.⁴ Anderson, J.W.⁵ Elam, M.B.⁶ Faas, F.H.⁷ Linares, E.⁸ Schaefer, E.J.⁹ Schectman, G.¹⁰ Wilton, T.J.¹¹ Wittes, J.¹²

7
- 0034604225
- Secondary prevention by raising HDL-cholesterol and reducing triglycerides in patients with coronary artery disease; the Bezafibrate Infarction Prevention (BIP) Study
- The BIP Study Group
- (2000) Circulation , vol.102 , pp. 21-27

8
- 0032572086
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
- For the AFCAPS/TexCAPS Research Group
- (1998) JAMA , vol.279 , pp. 1615-1622
- Downs, J.R.¹ Clearfield, M.² Weiss, S.³ Whitney, E.⁴ Shapiro, D.R.⁵ Beere, P.A.⁶ Langendorfer, A.⁷ Stein, E.A.⁸ Kruyer, W.⁹ Gotto, A.M.¹⁰

9
- 0033379344
- Fibrates, dyslipoproteinaemia and cardiovascular disease
- (1999) Curr Opin Lipidol , vol.10 , pp. 561-574
- Watts, G.F.¹ Dimmitt, S.B.²

10
- 0342981862
- The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
- (1996) N Engl J Med , vol.335 , pp. 1001-1009
- Sacks, F.M.¹ Pfeffer, M.A.² Moye, L.A.³ Rouleau, J.L.⁴ Rutherford, J.D.⁵ Cole, T.G.⁶ Brown, L.⁷ Theroux, P.⁸ Warnica, J.W.⁹ Arnold, J.M.¹⁰ Nash, D.T.¹¹ Wun, C.C.¹² Davis, B.R.¹³ Hawkins, C.M.¹⁴ Braunwald, E.¹⁵

11
- 0032487931
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
- The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
- (1998) N Engl J Med , vol.339 , pp. 1349-1357

12
- 0023232216
- Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
- (1987) N Engl J Med , vol.317 , pp. 1237-1245
- Frick, M.H.¹ Elo, O.² Haapa, K.³ Heinonen, O.P.⁴ Heinsalmi, P.⁵ Huttunen, J.K.⁶ Kaitaniemi, P.⁷ Koskinen, P.⁸ Manninen, V.⁹

13
- 0342879940
- Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
- (2000) Circulation , vol.101 , pp. 477-484
- Gotto, A.M.¹ Whitney, E.² Stein, E.A.³ Shapiro, D.R.⁴ Clearfield, M.⁵ Weiss, S.⁶ Jou, J.Y.⁷ Langendorfer, A.⁸ Beere, P.A.⁹ Watson, D.J.¹⁰ Downes, J.R.¹¹ de Cani, J.S.¹²

14
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- For the West of Scotland Coronary Prevention Study Group
- (1995) N Eng J Med , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, C.G.⁴ Lorimer, A.R.⁵ Macfarlane, P.W.⁶ McKillop, J.H.⁷ Packard, C.J.⁸

15
- 0029982038
- Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
- (1996) Lancet , vol.347 , pp. 849-853
- Ericsson, C.-G.¹ Hamsten, A.² Nilsson, J.³ Grip, L.⁴ Svane, B.⁵ de Faire, U.⁶

16
- 0342506477
- Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL-cholesterol
- The Lopid Coronary Angiography Trial (LOCAT) Study Group.
- (1997) Circulation , vol.96 , pp. 2137-2143
- Frick, M.H.¹ Syvänne, M.² Nieminen, M.S.³ Kauma, H.⁴ Majahalme, S.⁵ Virtanen, V.⁶ Kesäniemi, Y.A.⁷ Pasternack, A.⁸ Taskinen, M.-R.⁹

17
- 0032912006
- Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy
- (1999) Circulation , vol.99 , pp. 736-743
- Ballantyne, C.M.¹ Herd, A.J.² Ferli, C.L.L.³ Dunn, J.K.⁴ Farmer, J.A.⁵ Jones, P.H.⁶ Schein, J.R.⁷ Gotto, A.M.⁸

18
- 0033393022
- Low-density lipoprotein-independent effects of statins
- (1999) Curr Opin Lipidol , vol.10 , pp. 543-559
- Davignon, J.¹ Laaksonen, R.²

19
- 0035962077
- Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: A randomised controlled trial
- For the VA-HIT Study Group.
- (2001) JAMA , vol.285 , pp. 1585-1591
- Robins, S.J.¹ Collins, D.² Wittes, J.T.³ Papademetriou, V.⁴ Deedwania, P.C.⁵ Schaefer, E.J.⁶ McNamara, J.R.⁷ Kashyap, M.L.⁸ Hershman, J.M.⁹ Wexler, L.F.¹⁰ Rubins, H.B.¹¹

20
- 0032816777
- Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
- (1999) Curr Opin Lipidol , vol.10 , pp. 245-257
- Fruchart, J.-C.¹ Duriez, P.² Staels, B.³

21
- 0034700637
- Nonpharmacologic management of low levels of high-density lipoprotein cholesterol
- (2000) Am J Cardiol , vol.86 , Issue.SUPPL.
- Ginsberg, H.N.¹

22
- 0035863517
- Normocholesterolaemic dyslipidaemia: Is there a role for fibrates?
- (2001) Med J Aust , vol.174 , pp. 66-67
- Watts, G.F.¹ Dimmitt, S.B.² Barter, P.J.³

23
- 0031922041
- Cardiovascular outcomes in Type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: The St Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
- The SENDCAP Study Group.
- (1998) Diabetes Care , vol.21 , pp. 641-648
- Elkeles, R.S.¹ Diamond, J.R.² Poulter, C.³ Dhanjel, S.⁴ Nicolaides, A.N.⁵ Mahmood, S.⁶ Richmond, W.⁷ Mather, H.⁸ Sharp, P.⁹ Feher, M.D.¹⁰

24
- 0032497945
- Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels
- For the CARE Investigators.
- (1998) Circulation , vol.98 , pp. 2513-2519
- Goldberg, R.B.¹ Mellies, M.J.² Sacks, F.M.³ Moye, L.A.⁴ Howard, B.V.⁵ Howard, W.J.⁶ Davis, B.R.⁷ Cole, T.G.⁸ Pfeffer, M.A.⁹ Braunwald, E.¹⁰

25
- 0032542388
- Effect of niacin on atherosclerotic cardiovascular disease
- (1998) Am J Cardiol , vol.82
- Guyton, J.R.¹

26
- 77957126077
- Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in post menopausal women
- The Writing Group for the PEPI Trial.
- (1995) JAMA , vol.273 , pp. 199-208

27
- 0032547326
- Randomised trial of estrogen plus progestin for secondary prevention of heart disease in postmenopausal women: Heart and estrogen/progestin Replacement Study (HERS) Research Group
- (1998) JAMA , vol.280 , pp. 605-613
- Hulley, S.¹ Grady, D.² Bush, T.³ Furberg, C.⁴ Herrington, D.⁵ Riggs, B.⁶ Vittinghoff, E.⁷

28
- 0034685403
- Major cardiovascular events in the hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
- (2000) JAMA , vol.283 , pp. 1967-1975

29
- 0033547769
- Gene targets and approaches for raising HDL
- (1999) Circulation , vol.99 , pp. 12-14
- van Vlijmen, B.J.M.¹ Herz, J.²

30
- 0031724322
- Treatment strategies for management of serum lipids: Lessons learned from lipid metabolism, recent clinical trials, and experience with the HMGCoA reductase inhibitors
- (1998) Prog Cardiovasc Dis , vol.41 , pp. 95-116
- Rubenfire, M.¹ Coletti, A.T.² Mosca, L.³

31
- 0032987038
- Indications for cholesterol-lowering medication: Comparison of risk-assessment methods
- (1999) Lancet , vol.353 , pp. 278-281
- Durrington, P.N.¹ Prais, H.² Bhatnagar, D.³ France, M.⁴ Crowley, V.⁵ Khan, J.⁶ Morgan, J.⁷

32
- 0000732229
- CHD risk equations, obtained from the Framingham Heart Study, applied to the PROCAM Study
- (1991) Cardiovasc Risk Factors , vol.1 , pp. 126-133
- Schulte, H.¹ Assmann, G.²

33
- 0026754428
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience): Prospective Cardiovascular Munster Study
- (1992) Am J Cardiol , vol.70 , pp. 733-737
- Assmann, G.¹ Schulte, H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.